Altman Peter Insider Trading Activity
Corporate InsiderCEO · CIK 1647542
Altman Peter has been net-buying over the last 12 months with 23 purchases and 0 sales across 1 company.
BCDA is the most-traded position with 23 trades. The largest single transaction was a purchase of BCDA for $60K on Sep 19, 2025.
Performance Scorecard
Forward stock performance after each transaction by Altman Peter. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | -3.1% | — | 48% | 23 |
| 90 days | -16.8% | — | 6% | 16 |
| 120 days | -21.8% | — | 7% | 14 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersBCDA · BioCardia, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Altman Peter bought and sold BCDA.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 17, 2026 | BCDA | Buy | 500 | $0.83 | $415 | +0.1% | CEO | |
Jul 8, 2026 | BCDA | Buy | 5,400 | $0.96 | $5K | +1.5% | CEO | |
Jun 18, 2026 | BCDA | Buy | 800 | $0.96 | $768 | +0.3% | CEO | |
Jun 17, 2026 Filed 3d late | BCDA | Buy | 1,500 | $0.85 | $1K | +0.5% | CEO | |
May 20, 2026 | BCDA | Buy | 1,500 | $0.92 | $1K | +0.5% | CEO | |
May 19, 2026 | BCDA | Buy | 200 | $0.95 | $190 | +0.1% | CEO | |
May 18, 2026 | BCDA | Buy | 5,700 | $0.92 | $5K | +2.0% | CEO | |
May 15, 2026 | BCDA | Buy | 5,100 | $1.02 | $5K | +1.8% | CEO | |
Apr 29, 2026 | BCDA | Buy | 5,000 | $1.11 | $6K | +1.8% | CEO | |
Apr 21, 2026 | BCDA | Buy | 400 | $1.23 | $492 | +0.1% | CEO | |
Apr 20, 2026 | BCDA | Buy | 600 | $1.23 | $738 | +0.2% | CEO | |
Mar 25, 2026 | BCDA | Buy | 300 | $1.22 | $366 | +0.1% | CEO | |
Mar 24, 2026 | BCDA | Buy | 600 | $1.24 | $744 | +0.2% | CEO | |
Feb 4, 2026 | BCDA | Buy | 5,000 | $1.13 | $6K | +1.9% | CEO | |
Jan 21, 2026 | BCDA | Buy | 300 | $1.34 | $402 | +0.1% | CEO | |
Jan 20, 2026 | BCDA | Buy | 600 | $1.32 | $792 | +0.2% | CEO | |
Dec 17, 2025 | BCDA | Buy | 900 | $1.30 | $1K | +0.3% | CEO | |
Dec 16, 2025 | BCDA | Buy | 200 | $1.37 | $274 | +0.1% | CEO | |
Sep 19, 2025 | BCDA | Buy | 48,000 | $1.25 | $60K | +28.4% | CEO | |
Aug 22, 2025 | BCDA | Buy | 700 | $1.83 | $1K | +0.4% | CEO | |
Aug 13, 2025 | BCDA | Buy | 100 | $1.83 | $183 | +0.1% | CEO | |
Aug 12, 2025 | BCDA | Buy | 400 | $1.75 | $700.4 | +0.2% | CEO | |
Aug 11, 2025 | BCDA | Buy | 1,700 | $1.76 | $3K | +1.0% | CEO | |
Jun 30, 2025 | BCDA | Buy | 24,096 | $2.08 | $50K | +17.0% | CEO | |
May 30, 2025 | BCDA | Buy | 100 | $2.21 | $221 | +0.1% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| BCDA | BioCardia, Inc. | 25 | $151K |